ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Exploring Vitamin Treatments for Hidradenitis Suppurativa: Focus on Isotretinoin
January 30, 2024Hidradenitis Suppurativa (HS) is a chronic inflammatory skin condition characterized by painful nodules, abscesses, and tunnels developing in areas where skin rubs together. -
MC2 Therapeutics Acquires Option to Phase 2 Oral Drug Candidate for Hidradenitis Suppurativa and Other Indications
November 06, 2023MC2 Therapeutics announced today that it has acquired option rights from Regranion, LLC to exclusively license Regranion’s RGRN-305 for the treatment of all human diseases, incl, oral treatment of HS globally, excluding the greater China region. -
Risk for Long-Term Opioid Use Up in Hidradenitis Suppurativa
September 12, 2019Patients with hidradenitis suppurativa (HS) have an increased risk for long-term opioid use, according to a study published online in JAMA Dermatology.
Pharma Sources Insight January 2025
